AzTrials
AzTrials

Substance Use DisordersCUSPNCT04198974

The Canadian Underage Substance Use Prevention Trial

A study testing PreVenture Training (PTtT) and PreVenture Training+Implementation Facilitation in people with Substance Use Disorders and Adolescent Behavior, run by St. Justine's Hospital at 4 sites in Canada.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Despite having made some strides with respect to reducing adolescent drinking rates, illicit substance use and substance use disorders (SUDs) remain significantly above national targets for health promotion and disease prevention in Canada and the United States. Read more about this study

Who is it for?
Ages 15 to 16 yearsHealthy volunteers can take part
What is being tested?
PreVenture Training (PTtT) and PreVenture Training+Implementation Facilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
12,500 participants
Where
4 sitesCanada
Study dates
1 Dec 2019to Apr 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 16 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Survey: All year 10 students with youth consent and parental passive or active consent (depending on local site requirements) will be eligible to participate in the survey
  • PreVenture: Eligibility will include consenting to study protocol and scoring 0.9 or more Standard Deviations (SD) above the school's norm on the 23-item Substance Use Risk Profile Scale (SURPS). The SURPS is a 23-item validated tool that assesses four personality dimensions along the internalizing (hopelessness (HOP) and anxiety sensitivity (AS)) and externalizing (impulsivity (IMP) and sensation seeking (SS)) spectrum. It has been shown to predict specific substance use patterns, including cannabis use and non-medical use of prescription drugs. Of those screened in a given year, approximately 1350 (45%) will report elevated personality profiles and will be eligible for intervention.

Who cannot join

  • Students that do not have either the site-specific parental consent/assent or youth consent will not be eligible to participate in the survey or PreVenture

Trial locations and contacts

4 sites in 1 country.

Canada4 sites
  • Dalhousie University

    Halifax, Nova Scotia

  • University of British Columbia Okanagan Campus

    Kelowna, British Columbia

  • CHU Sainte-Justine Research Center

    Montreal, Quebec, H3T 1C5

  • Center for Mental Health and Addicitions

    Toronto, Ontario

Other trials in Canada

About this study

Despite having made some strides with respect to reducing adolescent drinking rates, illicit substance use and substance use disorders (SUDs) remain significantly above national targets for health promotion and disease prevention in Canada and the United States. Now, more than ever, there is a pressing need for effective substance abuse prevention in Canada, particularly for those most at risk of developing substance use problems including prescription drug misuse. Clearly, new approaches to prevention (with lower numbers needed to treat) are needed and which translate new research on addiction vulnerability to personalised prevention and early intervention. The PreVenture Program involves brief cognitive-behavioural interventions targeting personality traits from a neurocognitive perspective. While the personality-targeted approach has been shown to be effective in reducing most substance use behaviors, it has yet to be evaluated for its impact on uptake of prescription drug misuse in adolescents. The Canadian Underage Substance use Prevention (CUSP) Trial aims to evaluate the long-term effects of a personality-targeted school-based prevention program on delaying the onset of drug and alcohol use in adolescence over three years across Canada. This is a hybrid effectiveness [E] and implementation-facilitation [IF] trial on delaying the onset of drug and alcohol use in adolescence. In the [E] part, the effects of a personalized prevention program will be tested against usual school-based prevention curricula. PreVenture is delivered through a TtT implementation model with or without [IF], e.g. with ongoing supervision and web-based support. The [IF] package is designed to support long-term sustainability of PreVenture after a community accesses PreVenture training.

Read the detailed description

Aim:

To evaluate the effectiveness and implementation of the PreVenture program on reducing substance-related problems and substance use behaviours in adolescence when delivered in real-world school settings using a train-the-trainer (TtT) model, with and without implementation facilitation.

Questions:

This hybrid Type II effectiveness-implementation trial examines whether a personality-targeted prevention program, delivered through a TtT model, reduces substance-related problems and substance use behaviours among high-risk adolescents in routine school settings. In the effectiveness [E] part, the effects of PreVenture will be compared with usual school-based prevention curricula. PreVenture is delivered through a TtT implementation model with or without implementation facilitation [IF], consisting of ongoing coaching, supervision, and web-based support. The [IF] package is designed to support long-term sustainability of PreVenture after a community accesses PreVenture training.

[E] questions: Does the PreVenture intervention, when delivered through a TtT model (with or without IF), reduce the severity of substance-related problems among high-risk secondary school students compared with treatment as usual (primary)? Does the intervention reduce substance-related problems, binge drinking, cannabis use, illicit drug use, and non-medical prescription drug use at approximately 12 and 24 months post-baseline (secondary)? Does the intervention demonstrate sustained effects across available follow-up assessments (secondary)?

[IF] questions: Does the addition of the implementation facilitation [IF] package improve implementation outcomes (feasibility, reach, fidelity, sustainability) compared with the standard PreVenture TtT model?

Design:

Three sites (Nova Scotia, Ontario, British Columbia) participated in the trial. Each site recruited up to 9-10 high schools, randomised to one of three intervention conditions. Twenty-nine schools were randomised in total. Schools that withdrew prior to the baseline survey were replaced with another school assuming the same randomised intervention condition.

  1. Treatment-As-Usual (TAU) control: standard curriculum and mental health care.
  2. TtT PreVenture delivered using a train-the-trainer model (PTtT): Locally certified trainers provide structured PreVenture training to school-based professionals, who subsequently deliver the intervention to students.
  3. TtT PreVenture with Implementation Facilitation (PTtT+IF): In addition to PTtT, schools receive enhanced implementation support, including: a) involvement of youth in promoting the program, b) ongoing coaching and supervision sessions for group facilitators, and c) access to easy-to-use performance metrics.

Each school screened all consenting Grade 10 students using the Substance Use Risk Profile Scale (SURPS). A small number of schools also screened Grade 9 students as part of local implementation decisions. Students were enrolled across three successive cohorts. Cohort 1 completed follow-up assessments at approximately 12 and 24 months post-baseline; Cohort 2 completed a single follow-up at approximately 12 months post-baseline; Cohort 3 contributed baseline screening and implementation data only and did not complete post-baseline effectiveness assessments.

The primary analysis population includes high-risk students - defined as scoring at least 0.9 standard deviations above school-based norms on one or more SURPS subscales - from Cohorts 1 and 2 attending randomised schools that contributed at least one post-baseline assessment. Students will be analysed according to their school's randomised assignment, regardless of intervention participation or level of follow-up completion.

The PreVenture program is a personality-targeted prevention program designed to help youth understand their target personality trait and develop adaptive coping strategies using motivational and cognitive restructuring techniques. Four personality-specific motivational pathways to substance misuse are targeted: hopelessness, anxiety sensitivity, impulsivity, and sensation seeking. PreVenture involves two 90-minute group sessions, with one week separating each session. Sessions use structured manuals incorporating psychoeducational, motivational enhancement, and cognitive-behavioural therapy components.

Main Hypotheses:

[E] Primary hypothesis: Among adolescents identified as high risk based on SURPS personality profiles, assignment to PreVenture delivered via a TtT model (with or without IF) will reduce the probability of screening positive on the CRAFFT tool (score ≥2) at follow-up compared with assignment to treatment as usual.

[E] Secondary hypotheses:

  1. Assignment to PreVenture (PTtT or PTtT+IF) will reduce substance-use behaviours at follow-up, including binge drinking, cannabis use, illicit drug use, and non-medical use of prescription drugs, compared with treatment as usual.
  2. Intervention effects on substance-related problem severity and substance-use behaviours will be sustained across available follow-up assessments.

[IF] Outcomes:

  1. Fidelity: Schools randomised to receive IF will demonstrate higher implementation fidelity during delivery of PreVenture sessions compared with schools receiving PreVenture without IF.
  2. Sustainability: Schools in the IF condition will be more likely to continue delivering PreVenture beyond the initial implementation period.
  3. Reach: Schools in the IF condition will deliver both PreVenture sessions to a greater proportion of eligible high-risk students compared with schools without IF.
  4. Uptake of IF components: Among IF schools, engagement with individual IF components (youth promotion activities, ongoing coaching and supervision, and use of performance metric tools) will be described to characterise interest in and utilisation of the different implementation support strategies.
  5. Student feedback: Students in the IF condition will report higher perceived alignment between session content and core PreVenture learning goals, reflecting higher-quality implementation.

Data analyses strategy for [E]:

Primary and secondary effectiveness analyses will include all students identified as high risk at baseline using the SURPS who attended randomised schools contributing at least one post-baseline cluster-level assessment, and who contributed at least one post-baseline individual outcome assessment. Students will be analysed according to the randomised assignment of their school, regardless of intervention participation or level of follow-up completion. For effectiveness analyses, the two intervention arms (PTtT and PTtT+IF) will be pooled into a single arm, as the content of the PreVenture intervention is identical across delivery conditions.

The primary effectiveness outcome is CRAFFT-positive screening, defined as a CRAFFT score ≥2. The primary estimand is the average treatment effect of assignment to PreVenture across all post-baseline assessments, estimated using mixed-effects logistic regression models pooling all available follow-up waves. Models will include a school-level random intercept, an individual-level random intercept (dropped if variance is estimated at zero), and fixed effects for treatment condition, wave, cohort, baseline CRAFFT score, and additional baseline covariates (age, sex, province, SURPS subscale scores). Results will be reported as adjusted odds ratios with 95% confidence intervals, alongside marginal predicted probabilities and risk differences estimated via marginal standardisation. The primary hypothesis will be evaluated at a two-sided α = 0.05. Given the small number of contributing clusters, the Kenward-Roger correction will be applied to adjust degrees of freedom and standard errors.

Secondary behavioural outcomes - including binge drinking, cannabis use, illicit drug use, and non-medical prescription drug use - will be analysed using the same model structure. Binary outcomes will use mixed-effects logistic regression; ordinal frequency outcomes will use proportional odds mixed-effects regression.

Secondary analyses will examine: (1) wave-specific treatment effects in Cohort 1 to assess whether intervention effects are sustained over time; and (2) complier average causal effect (CACE) analyses using school-level randomisation as an instrumental variable for session attendance. Secondary analyses are exploratory and no multiplicity adjustment will be applied.

Missing outcome data will be handled using full maximum likelihood estimation under the missing at random (MAR) assumption, incorporating all available repeated measurements without requiring complete cases. A pre-specified inverse probability weighting (IPW) sensitivity analysis will assess the influence of attrition on study conclusions by upweighting students with observed outcomes whose baseline characteristics resemble those lost to follow-up.

Data analysis strategy for [IF]:

Analyses of implementation outcomes will be descriptive and will focus on fidelity, reach, uptake of IF components, sustainability, and student feedback across intervention arms. Implementation outcomes will be summarised for schools randomised to PTtT+IF and compared descriptively with schools receiving PTtT alone. These analyses will draw primarily on data from Cohorts 2 and 3. The trial was not powered for formal inferential testing of implementation outcomes.

The following implementation outcomes will be assessed:

  1. Fidelity and adherence: quality of PreVenture delivery will be assessed using the PreVenture Intervention Fidelity and Adherence (PIFA) scale, summarised by arm and cohort, and reported separately by facilitator type where available.
  2. Reach: the proportion of eligible high-risk students who received both PreVenture sessions will be calculated per school and summarised by arm and cohort.
  3. Uptake of IF components: the proportion of IF schools engaging in youth-promotion activities, coaching and supervision sessions, and use of performance-metric tools will be reported.
  4. Sustainability: the proportion of schools continuing to deliver PreVenture in Cohort 3 will be reported by arm and by whether delivery was school-led or externally supported.
  5. Student feedback: descriptive summaries of student responses to open-ended and precoded questions about intervention content, likes, dislikes, and learning objectives will be reported by arm and cohort.

Structured reflections completed by research staff will be summarised narratively to contextualise quantitative implementation findings and characterise variation in delivery conditions across provinces and cohorts.

Being tested
PreVenture Training (PTtT), PreVenture Training+Implementation Facilitation
Keywords
Prevention, Early intervention, Substance Use and Misuse, Mental Health, Personality-targeted Interventions, Adolescence
Medical subject headings
Substance-Related Disorders, Adolescent Behavior, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PreVenture Training (PTtT)Behavioural

    Also called PreVenture

    PreVenture TtT model will involve identifying local expert trainers to be trained to train school-based professionals on the PreVenture program. Steps include:

    1. PreVenture Facilitator certification: Trainers participate in training workshops and deliver the program to eligible youth in Cohort 1 and are rated on quality of implementation using the PIFA.
    2. Reliable use of the PIFA: Each trainer demonstrates convergence with the Montreal Team's ratings on a set of previously-recorded PreVenture sessions.
    3. PreVenture Training Workshop Certification: Trainers participate in a one-day TtT workshop to review the main aims and exercises of PreVenture Training. Trainers then record mock TtT sessions in which key components of the PreVenture Training Workshop are delivered to an audience of 4-10 individuals (e.g., class of graduate students). These sessions are rated by the Montreal Team the PreVenture Implementation Fidelity and Adherence-Trainer Scale (PIFA-T).
  • PreVenture Training+Implementation FacilitationBehavioural

    Also called PreVenture+IF

    PreVenture TtT model + Implementation Facilitation Package:

    1. Youth advisors identified the role of older youth to support program implementation. Youth will help promote PreVenture to students and families and help Facilitators optimize attendance at sessions.
    2. Trainer-led coaching sessions will focus on enhancing program fidelity and acceptability by Facilitators. 'Best practice' supervision elements from efficacy trials will be integrated. Fidelity and symptom monitoring will be conducted in real-time during program implementation.
    3. Performance metrics have been developed based on youth qualitative feedback to PreVenture sessions in previous trials. Analysis indicates key responses that are predictive of students most likely to benefit from PreVenture on 12-month substance use outcomes and indicates the extent to which Facilitator's interventions are leaving students with impressions consistent with positive long-term outcomes.
Study groups in NCT04198974
Study groupRoleWhat they receive
PreVenture Training (PTtT)ExperimentalSchools randomized to this arm will identify 4 staff members to participate in a 2-day training workshop + 3 hours of supervised practice and will be provided with access to screening and PreVenture intervention materials through the local trainer. Local trainers will deliver 2-day workshops and then supervise school staff in the delivery of two 90-minute group sessions (for at least one personality profile).
Receives: Behavioral: PreVenture Training (PTtT)
PreVenture Training + Implementation Facilitation (PTtT+IF)ExperimentalSchools randomized this arm will receive the standard PreVenture TtT protocol plus an additional Implementation Facilitation package that will contain 3 new components designed to increase the likelihood that schools will continue to implement the program with high quality and satisfaction: 1) Youth Engagement, 2) ongoing coaching and supervision for Facilitators, and 3) access to easy-to-use performance metrics.
Receives: Behavioral: PreVenture Training+Implementation Facilitation
Control (TAU)No interventionFor schools randomized to this arm, students will have usual access to drug and alcohol prevention through the standard curriculum and mental health care provided through student counseling at the participating schools. The schools will be incentivized to participate in the study with the promise of free PreVenture training and materials in subsequent years of the trial. Information on other drug prevention efforts implemented at the school will be collected, but the randomized design should control for any potential differences between intervention conditions on this random factor.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Effectiveness (primary): Risk of substance use problems

    The primary effectiveness outcome is CRAFFT-positive screening, defined as a CRAFFT total score ≥2, indicating elevated risk of substance-related problems. Effectiveness will be assessed by comparing changes in the proportion of adolescents screening CRAFFT-positive in schools randomized to PreVenture (both implementation arms pooled) versus treatment as usual (TAU).

    The CRAFFT Screening Test is a short clinical assessment tool designed to screen for substance-related risks and problems in adolescents. CRAFFT stands for the key words of the 6 items in the second section of the assessment - Car, Relax, Alone, Forget, Friends, Trouble. CRAFFT employs a skip pattern: participants whose Part A score is "0" (no use) answer the Car question only of Part B, while those who report any use in Part A also answer Part B's five CRAFFT questions. Each "yes" answer is scored as "1" point and a CRAFFT total score of two or higher identifies elevated risk for a substance use disorder.

    Measured: Baseline to 24 months

Secondary outcomes (9)
  1. Effectiveness (secondary): Binge drinking

    Any binge drinking among adolescents identified as high risk in schools randomised to PreVenture (both intervention arms pooled) versus TAU.

    Binge drinking will be assessed by a sub-item from the Alcohol Use Disorders Identification Test (AUDIT), asking "How often do you have five or more drinks on one occasion?" A binary indicator will be derived, coded 1 if the student responded "Less than monthly", "Monthly", "Weekly", or "Daily or almost daily", and 0 if the student responded "Never". This reflects any binge drinking in the past 12 months.

    Measured: Baseline to 24 months

  2. Effectiveness (secondary outcome): Cannabis use

    Any cannabis use in the past 12 months among adolescents identified as high risk in schools randomised to PreVenture versus TAU.

    Cannabis use will be assessed by asking: "Have you used cannabis in the last 12 months?" [options: yes/no]. A binary indicator will be derived, coded 1 for any use in the past 12 months and 0 for no use.

    Measured: Baseline to 24 months

  3. Effectiveness (secondary): Non-medical prescription drug use

    Any non-medical prescription drug (NMPD) use in the past 12 months among adolescents identified as high risk in schools randomised to PreVenture versus TAU.

    NMPD use will be assessed by asking: "Have you used prescription drugs for non-medical use (without a doctor's prescription) in the last 12 months?" [options: yes/no]. A binary indicator will be derived, coded 1 for any use in the past 12 months and 0 for no use.

    Measured: Baseline to 24 months

  4. Effectiveness (secondary outcome): Illicit substance use

    Any illicit substance use in the past 12 months among adolescents identified as high risk in schools randomised to PreVenture versus TAU.

    Illicit substance use will be assessed by asking whether the student used any of the following substances in the last 12 months: solvents, cocaine, MDMA, methamphetamine, heroin, fentanyl, psilocybin, LSD, steroids, or PCP [options: yes/no for each]. A binary indicator will be derived, coded 1 if the student reported use of any of these substances in the past 12 months and 0 if no substances were reported.

    Measured: Baseline to 24 months

  5. Implementation Outcomes: Reach

    Proportion of eligible high-risk students completing both Preventure sessions between schools receiving PreVenture by standard Train-the-Trainer (PTtT) vs. PTtT with implementation facilitation (IF) support.

    Measured: Baseline to 36 months

  6. Implementation Outcomes: Fidelity

    Level of adherence to core program components and overall delivery quality using the PreVenture Intervention Fidelity and Adherence (PIFA) scale between schools receiving PreVenture by standard Train-the-Trainer (PTtT) vs. PTtT with implementation facilitation (IF) support.

    Measured: Baseline to 36 months

  7. Implementation Outcomes: Student-reported acceptability of PreVenture

    Alignment of student-reported learning reported in brief student feedback surveys with key Preventure goals using the validated performance-metric theme grid between schools receiving PreVenture by standard Train-the-Trainer (PTtT) vs. PTtT with implementation facilitation (IF) support.

    Measured: Baseline to 36 months

  8. Implementation Outcomes: Uptake of IF components

    Proportion of Preventure + IF schools that engaged with youth-promotion activities, coaching/supervision, and performance-metric tools

    Measured: Baseline to 36 months

  9. Implementation Outcomes: Sustainability

    Proportion of schools (PreVenture TtT vs. PTtT+IF) that continue to deliver the intervention in Cohort 3 (implementation cohort).

    Measured: Baseline to 36 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Dec 2019
  2. Study start1 Dec 2019
  3. Primary completionApr 2026 (estimated)
  4. Study completionApr 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Hybrid effectiveness/implementation randomized control trial
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
12,500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04198974
Sponsor's protocol ID
CUSP Trial
Acronym
CUSP
Status last verified
Apr 2026
First submitted
4 Dec 2019
Last updated
27 Apr 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Conrod PJ. Personality-Targeted Interventions for Substance Use and Misuse. Curr Addict Rep. 2016;3(4):426-436. doi: 10.1007/s40429-016-0127-6. Epub 2016 Nov 4.

    PubMed 27909645
  • Woicik PA, Stewart SH, Pihl RO, Conrod PJ. The Substance Use Risk Profile Scale: a scale measuring traits linked to reinforcement-specific substance use profiles. Addict Behav. 2009 Dec;34(12):1042-55. doi: 10.1016/j.addbeh.2009.07.001. Epub 2009 Jul 8.

    PubMed 19683400
  • Conrod PJ, O'Leary-Barrett M, Newton N, Topper L, Castellanos-Ryan N, Mackie C, Girard A. Effectiveness of a selective, personality-targeted prevention program for adolescent alcohol use and misuse: a cluster randomized controlled trial. JAMA Psychiatry. 2013 Mar;70(3):334-42. doi: 10.1001/jamapsychiatry.2013.651.

    PubMed 23344135
  • O'Leary-Barrett M, Mackie CJ, Castellanos-Ryan N, Al-Khudhairy N, Conrod PJ. Personality-targeted interventions delay uptake of drinking and decrease risk of alcohol-related problems when delivered by teachers. J Am Acad Child Adolesc Psychiatry. 2010 Sep;49(9):954-963.e1. doi: 10.1016/j.jaac.2010.04.011. Epub 2010 Jul 31.

    PubMed 20732631

Questions about this trial

What is this clinical trial studying?

A study testing PreVenture Training (PTtT) and PreVenture Training+Implementation Facilitation in people with Substance Use Disorders and Adolescent Behavior, run by St. Justine's Hospital at 4 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 27 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Effectiveness (primary): Risk of substance use problems (time frame: Baseline to 24 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04198974, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Apr 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in